Personalized radiotherapy benefit prediction in non-surgically managed prostate adenocarcinoma: a prognostic nomogram for survival risk stratification
The developed nomograms effectively identify patients likely to benefit from radiotherapy. High-risk patients experience significant OS and CSS benefits, while radiotherapy is not recommended for low-risk patients.
Authors
- Yongyong Shi (ORCID: https://orcid.org/0000-0003-1710-1505)
- Junfeng Jing
- Can Wei (ORCID: https://orcid.org/0000-0003-4291-7653)
- Yanbin Zhang (ORCID: https://orcid.org/0000-0002-6292-8352)
- Lang Wang (ORCID: https://orcid.org/0000-0002-8303-5633)
- Junhua Xi
Institutions
- Anhui Medical University (CN)
- Third People's Hospital of Hefei (CN)
Publication Details
- Journal
- Translational Andrology and Urology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tau-2025-434
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00